BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,096 filers reported holding BAXTER INTL INC in Q4 2020. The put-call ratio across all filers is 0.87 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $497 | -19.6% | 13,180 | -2.8% | 0.30% | -15.1% |
| Q2 2023 | $618 | +8.8% | 13,555 | -3.2% | 0.35% | +8.3% |
| Q1 2023 | $568 | -56.6% | 14,005 | -45.4% | 0.32% | -56.8% |
| Q4 2022 | $1,308 | -99.9% | 25,655 | -14.9% | 0.75% | -26.0% |
| Q3 2022 | $1,623,000 | -28.4% | 30,142 | -14.6% | 1.02% | -23.3% |
| Q2 2022 | $2,267,000 | -26.9% | 35,298 | -11.8% | 1.33% | -12.4% |
| Q1 2022 | $3,103,000 | -10.8% | 40,023 | -1.2% | 1.52% | -7.9% |
| Q4 2021 | $3,478,000 | +5.6% | 40,513 | -1.1% | 1.64% | -2.8% |
| Q3 2021 | $3,295,000 | -2.5% | 40,962 | -2.4% | 1.69% | -3.6% |
| Q2 2021 | $3,380,000 | -4.5% | 41,987 | +0.0% | 1.76% | -10.6% |
| Q1 2021 | $3,541,000 | +3.8% | 41,986 | -1.3% | 1.96% | -6.3% |
| Q4 2020 | $3,413,000 | -1.0% | 42,536 | -0.8% | 2.10% | -12.5% |
| Q3 2020 | $3,449,000 | -7.4% | 42,886 | -0.9% | 2.40% | -11.4% |
| Q2 2020 | $3,725,000 | +5.1% | 43,260 | -0.9% | 2.70% | -9.7% |
| Q1 2020 | $3,543,000 | -5.8% | 43,635 | -3.0% | 3.00% | +20.2% |
| Q4 2019 | $3,762,000 | -5.3% | 44,984 | -1.0% | 2.49% | -14.0% |
| Q3 2019 | $3,974,000 | -1.3% | 45,434 | -7.6% | 2.90% | +0.8% |
| Q2 2019 | $4,026,000 | 0.0% | 49,159 | -0.7% | 2.88% | -2.8% |
| Q1 2019 | $4,026,000 | +20.5% | 49,508 | -2.5% | 2.96% | +8.8% |
| Q4 2018 | $3,341,000 | -15.2% | 50,758 | -0.6% | 2.72% | +1.3% |
| Q3 2018 | $3,939,000 | +3.1% | 51,090 | -1.2% | 2.69% | -4.3% |
| Q2 2018 | $3,819,000 | +12.7% | 51,715 | -0.7% | 2.81% | +15.9% |
| Q1 2018 | $3,388,000 | -4.6% | 52,090 | -5.2% | 2.42% | -1.3% |
| Q4 2017 | $3,553,000 | -10.8% | 54,973 | -13.4% | 2.46% | -12.3% |
| Q3 2017 | $3,985,000 | -17.8% | 63,503 | -20.7% | 2.80% | -10.8% |
| Q2 2017 | $4,848,000 | +16.0% | 80,073 | -0.6% | 3.14% | +3.8% |
| Q1 2017 | $4,179,000 | +14.5% | 80,573 | -2.1% | 3.02% | +16.5% |
| Q4 2016 | $3,649,000 | -7.4% | 82,298 | -0.5% | 2.60% | -1.5% |
| Q3 2016 | $3,939,000 | +4.6% | 82,753 | -0.7% | 2.64% | +1.4% |
| Q2 2016 | $3,767,000 | +6.7% | 83,313 | -3.0% | 2.60% | -6.3% |
| Q1 2016 | $3,529,000 | +7.2% | 85,905 | -0.5% | 2.77% | +4.1% |
| Q4 2015 | $3,293,000 | +14.5% | 86,305 | -1.4% | 2.67% | +11.9% |
| Q3 2015 | $2,875,000 | -46.9% | 87,505 | +13.0% | 2.38% | -38.6% |
| Q2 2015 | $5,413,000 | -2.0% | 77,405 | -4.0% | 3.88% | +2.0% |
| Q1 2015 | $5,522,000 | -7.5% | 80,612 | -1.0% | 3.80% | -4.6% |
| Q4 2014 | $5,967,000 | +1.0% | 81,417 | -1.1% | 3.99% | +3.2% |
| Q3 2014 | $5,907,000 | – | 82,307 | – | 3.86% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SECTOR GAMMA AS | 713,500 | $49,895,000 | 12.74% |
| Veritas Asset Management LLP | 7,636,450 | $534,017,000 | 7.53% |
| FIRST NEW YORK SECURITIES LLC /NY | 154,158 | $10,780,269,000 | 5.40% |
| Gabalex Capital Management LLC | 200,000 | $14,981,000 | 5.39% |
| Veritas Investment Management LLP | 291,825 | $18,816,000 | 5.32% |
| Tweedy, Browne Co LLC | 2,543,966 | $177,900,000 | 4.91% |
| York Capital Management Global Advisors, LLC | 8,074,375 | $564,641,000 | 4.78% |
| First Fiduciary Investment Counsel, Inc. | 270,675 | $18,928,000 | 4.10% |
| SCHARF INVESTMENTS, LLC | 2,247,225 | $157,148,000 | 4.03% |
| Osher Van de Voorde Investment Management | 96,235 | $6,730,000 | 3.91% |